• Something wrong with this record ?

Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells

MAM. Rodrigo, H. Buchtelova, AMJ. Jimenez, P. Adam, P. Babula, Z. Heger, V. Adam,

. 2019 ; 8 (3) : . [pub] 20190312

Language English Country Switzerland

Document type Journal Article

Grant support
NV15-28334A MZ0 CEP Register

The efficiency of cisplatin (CDDP) is significantly hindered by the development of resistance during the treatment course. To gain a detailed understanding of the molecular mechanisms underlying the development of cisplatin resistance, we comparatively analyzed established a CDDP-resistant neuroblastoma cell line (UKF-NB-4CDDP) and its susceptible parental cells (UKF-NB-4). We verified increased chemoresistance of UKF-NB-4CDDP cells by analyzing the viability, induction of apoptosis and clonal efficiency. To shed more light on this phenomenon, we employed custom cDNA microarray (containing 2234 probes) to perform parallel transcriptomic profiling of RNA and identified that 139 genes were significantly up-regulated due to CDDP chemoresistance. The analyses of molecular pathways indicated that the top up-regulation scoring functions were response to stress, abiotic stimulus, regulation of metabolic process, apoptotic processes, regulation of cell proliferation, DNA repair or regulation of catalytic activity, which was also evidenced by analysis of molecular functions revealing up-regulation of genes encoding several proteins with a wide-spectrum of enzymatic activities. Functional analysis using lysosomotropic agents chloroquine and bafilomycin A1 validated their potential to re-sensitize UKF-NB-4CDDP cells to CDDP. Taken together, the identification of alterations in specific genes and pathways that contribute to CDDP chemoresistance may potentially lead to a renewed interest in the development of novel rational therapeutics and prognostic biomarkers for the management of CDDP-resistant neuroblastoma.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19013252
003      
CZ-PrNML
005      
20190411095712.0
007      
ta
008      
190405s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cells8030235 $2 doi
035    __
$a (PubMed)30871063
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rodrigo, Miguel Angel Merlos $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. merlos19792003@gmail.com. Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, CZ-616 00 Brno, Czech Republic. merlos19792003@gmail.com.
245    10
$a Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells / $c MAM. Rodrigo, H. Buchtelova, AMJ. Jimenez, P. Adam, P. Babula, Z. Heger, V. Adam,
520    9_
$a The efficiency of cisplatin (CDDP) is significantly hindered by the development of resistance during the treatment course. To gain a detailed understanding of the molecular mechanisms underlying the development of cisplatin resistance, we comparatively analyzed established a CDDP-resistant neuroblastoma cell line (UKF-NB-4CDDP) and its susceptible parental cells (UKF-NB-4). We verified increased chemoresistance of UKF-NB-4CDDP cells by analyzing the viability, induction of apoptosis and clonal efficiency. To shed more light on this phenomenon, we employed custom cDNA microarray (containing 2234 probes) to perform parallel transcriptomic profiling of RNA and identified that 139 genes were significantly up-regulated due to CDDP chemoresistance. The analyses of molecular pathways indicated that the top up-regulation scoring functions were response to stress, abiotic stimulus, regulation of metabolic process, apoptotic processes, regulation of cell proliferation, DNA repair or regulation of catalytic activity, which was also evidenced by analysis of molecular functions revealing up-regulation of genes encoding several proteins with a wide-spectrum of enzymatic activities. Functional analysis using lysosomotropic agents chloroquine and bafilomycin A1 validated their potential to re-sensitize UKF-NB-4CDDP cells to CDDP. Taken together, the identification of alterations in specific genes and pathways that contribute to CDDP chemoresistance may potentially lead to a renewed interest in the development of novel rational therapeutics and prognostic biomarkers for the management of CDDP-resistant neuroblastoma.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Buchtelova, Hana $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. hanabuchtelova@seznam.cz.
700    1_
$a Jimenez, Ana Maria Jimenez $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. anuskajj@hotmail.com. Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, CZ-616 00 Brno, Czech Republic. anuskajj@hotmail.com.
700    1_
$a Adam, Pavlina $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. Pavlina.adam@email.cz.
700    1_
$a Babula, Petr $u Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, CZ-616 00 Brno, Czech Republic. babula@med.muni.cz. Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic. babula@med.muni.cz.
700    1_
$a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. heger@mendelu.cz. Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, CZ-616 00 Brno, Czech Republic. heger@mendelu.cz.
700    1_
$a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic. vojtech.adam@mendelu.cz. Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, CZ-616 00 Brno, Czech Republic. vojtech.adam@mendelu.cz.
773    0_
$w MED00194911 $t Cells $x 2073-4409 $g Roč. 8, č. 3 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30871063 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411095729 $b ABA008
999    __
$a ind $b bmc $g 1392562 $s 1051557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 8 $c 3 $e 20190312 $i 2073-4409 $m Cells $n Cells $x MED00194911
GRA    __
$a NV15-28334A $p MZ0
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...